This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ji-Ye Hong: Innovator in Cancer Treatment
Introduction
Ji-Ye Hong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. His innovative work has garnered attention for its potential impact on cancer therapies.
Latest Patents
Ji-Ye Hong holds a patent for a Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer. This compound exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2). The invention suggests that the compound can be effectively utilized in cancer treatment, showcasing its potential as a valuable therapeutic agent.
Career Highlights
Hong is associated with Omic Smap Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
He collaborates with notable colleagues, including Jung Jin Hwang and Sang Eun Park, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Ji-Ye Hong's contributions to cancer treatment through his innovative patent highlight the importance of research in developing effective therapies. His work exemplifies the potential of scientific innovation to make a meaningful difference in healthcare.